Envoy Medical (COCH) Notes Payables (2022 - 2023)
Envoy Medical (COCH) reported Notes Payables of $311000.0 for Q4 2023, down 7.16% on a YoY basis from $335000.0 in Q4 2022, and up 36.4% sequentially from $228000.0 in Q3 2023.
Envoy Medical (COCH) Notes Payables (2022 - 2023) Analysis & Trends
Envoy Medical (COCH) has 2 years of Notes Payables data on file, last reported at $311000.0 in Q4 2023.
- For the quarter ending Q4 2023, Notes Payables fell 7.16% year-over-year to $311000.0; the trailing twelve-month figure through Dec 2023 stood at $311000.0 (down 7.16% YoY), and the FY2023 full-year result was $311000.0, down 7.16% from the prior year.
- Notes Payables improved to $311000.0 in Q4 2023, from $228000.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $335000.0 in Q4 2022 to a low of $228000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Envoy Medical | 45.50 Mn | 20.25 Mn | -274,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 311,000.00 |
| Sep 30, 2023 | 228,000.00 |
| Dec 31, 2022 | 335,000.00 |